Industry braces for updated access pathways
Canadians with inherited hyperlipidemia may soon see a new option
Are small independent pharmacies at risk under new insurer rules?
FLOW trial shows semaglutide cuts risk of kidney disease progression and cardiovascular death in T2D
Analysts expect obesity pill pricing to mirror injections as US$150 billion market takes shape by 2030
Trump’s tariff threat could pressure Canada’s drug pricing system and domestic production
